In implementing Covid-19 vaccination in Indonesia, the Food and Drug Supervisory Agency (BPOM) acts as a “referee” that oversees the entire vaccination process, from testing to vaccine distribution.
Technology has improved over time. At the end of the second decade of the 21st century, we witnessed the fastest development of vaccines in human history.
Indonesia's Covid-19 vaccination program will prioritize 1.4 million health workers as recipients in its initial stage. At least 181 million people must be vaccinated in order to form herd immunity.
Hospitals across the country have nearly reached full capacity as the number of Covid-19 patients who need to be treated in isolation continues to grow.
Efforts to control the transmission of COVID-19 will determine the success of the vaccination program.